Some peptides act as hormones, but not all peptides are hormones. Peptides are defined by their amino-acid structure; their biological roles vary widely.

Many signalling peptides occur naturally in the body, but therapeutic products are manufactured or compounded.

No. Some peptide-based medicines are approved for specific conditions, while many compounds marketed by wellness providers remain investigational or unapproved. Each product and proposed use must be assessed separately.

An approved medicine has undergone regulatory evaluation for a defined indication, formulation and dose. A research peptide has not yet been established as safe and effective for routine treatment.

No. As of July 2026, retatrutide remains under clinical investigation.

BPC-157 and TB-500 are emerging peptides which are proven for their potential to support tissue-repair pathways, healing responses, mobility and recovery following injury. They may be considered as part of a personalised recovery programme under appropriate medical supervision.

Research is still evolving, and individual results may vary.

They are compounds studied in relation to mitochondrial function and cellular energy. Their evidence, formulation and regulatory status differ.

These compounds are promoted for neurological or psychological effects, but evidence and approval vary by country. They are not substitutes for a proper evaluation of anxiety, depression, ADHD, sleep disturbance or neurological symptoms.

Epitalon is an emerging peptide being studied for its potential role in cellular health, sleep regulation, circadian rhythm and telomere-related ageing pathways. It is of growing interest within longevity research and may be considered as part of a personalised healthy-ageing programme under appropriate medical supervision.

Research is still evolving, and individual responses may vary.

No. NAD+ is a coenzyme involved in cellular energy and redox reactions. Although it is often grouped with peptide or longevity programmes, it is not a peptide.

No. NAD+ is a coenzyme involved in cellular energy and redox reactions. Although it is often grouped with peptide or longevity programmes, it is not a peptide.

Certain approved peptide-based medicines can support weight management in eligible patients when combined with nutrition, movement and medical monitoring. Not every peptide causes weight loss.

Some lean mass can be lost during weight reduction. Adequate protein, resistance training, appropriate calorie intake and body-composition monitoring can help reduce unnecessary muscle loss.

There is no universal timeline because peptides have different mechanisms and evidence. Any provider promising rapid results from all peptide therapies is oversimplifying the science.

Yes, selected peptides may be combined within a carefully designed and personalised protocol. Each peptide should have a clear purpose, with the combination chosen according to the individual’s health goals, medical history and investigations. Introducing therapies strategically and monitoring the response helps optimise benefits while prioritising safety.

Subcutaneous injections may cause brief discomfort, bruising, redness or swelling. Persistent redness, warmth, pus, fever or increasing pain requires medical review.

Yes. Peptides and impurities can trigger immune reactions.

Suitability depends on the specific medicine. Pregnancy, breastfeeding, childhood, cancer history, severe kidney or liver disease, pancreatic or gallbladder disease, endocrine conditions, eating disorders and significant medication interactions may alter or exclude treatment. A full clinical review is essential.

There is no single “peptide panel.” Testing is based on the treatment and clinical goal and may include glucose, HbA1c, lipids, kidney and liver function, thyroid markers, blood count, body composition or other specific investigations.

Patients cannot confirm safety from appearance or marketing alone. “Pharmaceutical grade,” a QR code or a certificate of analysis does not prove that an injectable is lawful, sterile, accurately dosed or appropriate for human use. Product sourcing should be handled through authorised channels.

No. These foundations remain central to metabolism, muscle, recovery and long-term health. Treatment should support—not replace—the behaviours that maintain results.

Contact the prescribing clinical team. Depending on the medicine and severity, the plan may require slower titration, dose adjustment may be required.

---

Suggested website disclaimer : The information on this page is for general education and does not constitute medical advice or promotion of an unapproved product. Peptide-based medicines are prescription treatments whose approval and lawful availability vary by country and indication. Several compounds discussed online remain investigational, with limited human safety and effectiveness data. Treatment decisions must be made with an appropriately qualified medical professional following individual assessment and informed consent.

Suggested SEO title : Peptide Therapy Consultation in Mumbai | Kiiran Patel Wellness Cube.

Suggested meta description : Explore peptide-based therapies with Kiiran Patel Wellness Cube, Mumbai. Understand approved versus investigational peptides, personalised assessment, safety and monitoring.